expectations

 

Judging criteria

Successful applicants will clearly articulate:

  • the service improvement or clinical research project

  • how the project challenges the status quo

  • the benefits to patients & the care team

Winners

Phase 1 (2018/19)

140 clinicians receive Medopad's remote patient monitoring services with full project management support. Services are worth up to £85,000 / $100,000 per team and are delivered free of charge. 

This is comprised of a one-off consultancy fee worth £35,000 / $50,000 and a yearly license fee of £15,000 / $20,000 for up to 100 patients and £50,000 / $70,000 for up to 1,000 patients.

Medopad can also provide data analysis and support to publish evaluation results. 

 

Phase 2 (2019/20)

2 clinicians selected to undertake joint research project focused on predicting disease complications and/or clinical deterioration. 

Each clinician receives AI and predictive analytic services worth up to £500,000 / $750,000 free of charge.


Key dates

 

All applicants

Competition release date
3 Sept 2018, 9am

Competition application deadline
8 Oct 2018, 9am

Competition winners announced
12 Oct 2018

Successful applicants

Project scope & agreement signed
Applicants to be available for 1 hour session
13 - 31 October 2018

Project kick-off & training
Applicants to be available for 1 hour session
13 Oct - 30 Nov 2018

Project on-boarding first patients!
As agreed in proposal


Eligibility

 

Clinical areas

70 projects within rare & complex diseases.

70 projects within acute & chronic conditions.

Projects with multiple/distinct patient cohorts need to complete a separate application.

Patients & cohort size

Adult cohorts.

Paediatric cohorts if their caregiver is the registrant on the Medopad app.

Projects will be prioritised for patient cohorts sizes of 10+ people (rare diseases) and 50+ people (acute & chronic diseases).

Eligible applicants

Energetic & innovative healthcare professionals (i.e. clinicians, including consultants, nurses, physiotherapists, etc).

 


Data & privacy

 

Compliance

Medopad is a CE-marked class 1 device and GDPR compliant

Medopad maintain its software and servers and reside within a secure network under ISO 27001 standards and has been extensively tested by many organisations. We maintain a Quality Management System (QMS) and through its processes regularly update our software incorporating user-feedback and client.

Medopad adheres to the following standards and legislation

● Health & Social Care (Safety & Quality) Act.

● ISO/IEC 27002: Information technology, Security techniques, Code of practice for information security controls

● ISO 27799: Health informatics, Information security management in health using ISO/IEC 27002

● ISO/IEC 27017: Security techniques, Code of practice for information security controls based on ISO/IEC 27002 for cloud services

● SCCI0129: Clinical Risk Management: Its application in the Manufacture of Health IT Systems

● SCCI0160: Clinical Risk Management: Its Application in the Deployment and Use of Health IT Systems

Data security & privacy policy

Data collection - Data is collected by users of Medopad - by patients on the app and by clinicians on their webportal. Medopad’s implementation team trains its users via a workshop. Our implementation team has received prior specialist training. This technical support is provided to users of Medopad as part of a service contract.

Data Access - All personally-identifiable data collected on Medopad is stored confidentially and is accessible to only patients and the clinicians chosen by them, known as authorised users. An authorised user can also be a medical professional whose employer (e.g. NHS hospital) has identified and authorised access. This process is recorded and regularly audited.

Data ownership - The copy of data in a patient’s account is owned by the patient. The copy of data in a clinician’s account is owned by the employer of the clinician. Patient, carers and clinicians can add new data and comments, and all additions are tracked with an audit trail. Medopad does not have access to individual accounts of clinicians or patients.

Data Encryption - Data is protected (at rest) using Server-Side Encryption with a strong, multi factor encryption key., the Amazon S3-Managed Encryption Keys (SSE-S3). Amazon SSE-S3 uses a 256-bit Advanced Encryption Standard (AES-256), to encrypt data. Amazon S3 encrypts each object with a unique key and as an additional safeguard, it encrypts the key itself with a master key that rotates regularly. All communications are encrypted and authenticated using TLS 1.2 (protocol), ECDHE_RSA with P-256 (key exchange), and AES_128_GCM (cipher) tdftfdfree6f 2048 bit keys.

Data anonymity - Third party and Medopad internal analysis is performed only on anonymised and aggregate data. We have processes in place to meet right to be forgotten requests as detailed in our privacy policy.